By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Magellan Biosciences and Miacom Diagnostics announced on Monday a partnership to bring Miacom's molecular tests to the US and Canada.

The combined offering covered by the agreement includes Magellan's Trek-brand VersaTrek microbial detection system, Miacom's lucesco IVD kits for the identification of bacteria and fungi/yeast from blood cultures, and Magellan's Trek Sensititre susceptibility-testing system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.